Biontech To Start Uk Cancer Vaccine Trials Using Same Mrna Tech Found In Its Covid 19 Shots
Following the Covid-19 vaccine rollouts, BioNTech wants to use the same messenger-ribonucleic-acid technology (mRNA) tech in other therapies, including cancer vaccines. The treatments, tailor-made for an individual, provide immune systems with genetic code from a specific cancer so only the tumor can be targeted. An improvement over chemotherapy, which attacks many cells, including healthy ones. Essentially, the mRNA vaccines will contain a genetic blueprint to stimulate the immune system to attack cancer cells only....